Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. identifies Nav1.7 channel blockers

June 11, 2018

Bristol-Myers Squibb divulges integrin alphaV antagonists

June 11, 2018

Dana-Farber Cancer Institute patents new PROTAC compounds for cancer

June 11, 2018

Roche patents anti-pY796-DDR1 antibodies

June 8, 2018

Seoul National University creates adenoviral vector encoding CRY1

June 8, 2018

Beijing Gegen Biotechnology, Yicon Medical Science and Technology Co. patent anti-EGFR antibodies

June 8, 2018

Guangdong Longchuangji Pharmacy Co. presents Lactobacillus rhamnosus strain

June 8, 2018

Bristol-Myers Squibb describes integrin alpha-V antagonists

June 8, 2018

Merck & Co. synthesizes new FXIIa inhibitors

June 7, 2018

Weishang Shanghai Bio-Pharmaceutical discovers mutant EGFR inhibitors

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...